A database of FDA approved therapeutic peptides and proteins
ID1005 | ThPPIDTh1002 | NameCetuximab | Peptide SequenceHeavy chain:QVQLKQSG Full view | Length243 | Functional ClassificationIIIc | DiseaseCancer | BrandErbitux | CompanyImClone Systems Inc | Physical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates | Route of AdministartionIntravenous infusion | CategoryAntineoplastic Agents | TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c |
ID1022 | ThPPIDTh1003 | NameDornase alfa | Peptide SequenceLKIAAFNIQTFGETKMSNAT Full view | Length255 | Functional ClassificationIb | DiseaseMetabolic | BrandPulmozyme | CompanyGenentech Inc | Physical AppearanceN.A. | Route of AdministartionAdministered by inhalation of an aerosol mist produced by a compressed air driven nebulizer system | CategoryEnzymes | TargetDNA |
ID1023 | ThPPIDTh1003 | NameDornase alfa | Peptide SequenceLKIAAFNIQTFGETKMSNAT Full view | Length255 | Functional ClassificationIb | DiseaseMetabolic | BrandViscozyme | CompanyRoche (Chile) | Physical AppearanceN.A. | Route of AdministartionAdministered by inhalation of an aerosol mist produced by a compressed air driven nebulizer system | CategoryEnzymes | TargetDNA |
ID1025 | ThPPIDTh1004 | NameDenileukin diftitox | Peptide SequenceMGADDVVDSSKSFVMENFSS Full view | Length255 | Functional ClassificationIIb | DiseaseCancer | BrandOntak | CompanySeragen Inc | Physical AppearanceSterile, white, preservative-free, lyophilized powder. | Route of AdministartionIntravenous(IV) administration | CategoryAntineoplastic Agents | TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma |
ID1028 | ThPPIDTh1005 | NameEtanercept | Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view | Length255 | Functional ClassificationIIa | DiseaseImmunological | BrandEnbrel | CompanyImmunex Corp | Physical AppearanceLyophilized powder. | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents | TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re |
ID1029 | ThPPIDTh1005 | NameEtanercept | Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view | Length255 | Functional ClassificationIIa | DiseaseImmunological | BrandEnbrel Sureclick | CompanyN.A. | Physical AppearanceSolution | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents | TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re |
ID1055 | ThPPIDTh1009 | NameAlteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandActivase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous | CategoryThrombolytic Agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1067 | ThPPIDTh1012 | NameReteplase | Peptide SequenceSYQGNSDCYFGNGSAYRGTH Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandRetavase | CompanyCentocor | Physical AppearanceSterile, white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryFibrinolytic Agents, Thrombolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1110 | ThPPIDTh1015 | NameInterferon alfa-n3 | Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view | Length235 | Functional ClassificationIb | DiseaseImmunological | BrandAlferon | CompanyInterferon Sciences Inc. | Physical AppearanceSolution | Route of AdministartionInjection | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1111 | ThPPIDTh1015 | NameInterferon alfa-n3 | Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view | Length235 | Functional ClassificationIb | DiseaseImmunological | BrandAlferon LDO | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1112 | ThPPIDTh1015 | NameInterferon alfa-n3 | Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view | Length235 | Functional ClassificationIb | DiseaseImmunological | BrandAlferon N Injection | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents | TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2 |
ID1142 | ThPPIDTh1020 | NameAsparaginase | Peptide SequenceQMSLQQELRYIEALSAIVET Full view | Length255 | Functional ClassificationIc | DiseaseCancer | BrandElspar | CompanyMerck & Co. Inc | Physical AppearanceLyophilized plug or powder | Route of AdministartionIntravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first. | CategoryAntineoplastic Agents | TargetL-asparagine |
ID1145 | ThPPIDTh1021 | NameThyrotropin Alfa | Peptide SequenceAlpha chain:APDVQDC< Full view | Length204 | Functional ClassificationIV | DiseaseCancer | BrandThyrogen | CompanyGenzyme Inc | Physical AppearanceLyophilized powder | Route of AdministartionIntramuscular preferably the buttocks | CategoryDiagnostic Agents | TargetThyrotropin receptor |
ID1148 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAdvate | CompanyN.A. | Physical AppearancePowder form | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1149 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandAlphanate | CompanyN.A. | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1150 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandBioclate | CompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc. | Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powder | Route of AdministartionIntravenous infusion | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1151 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHelixate FS | CompanyN.A. | Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrate | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1152 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHemofil M | CompanyN.A. | Physical AppearanceDry concentrate | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1153 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandHyate:C | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1154 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandKoate-HP | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1155 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandKogenate FS | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1156 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandMonarc-M | CompanyN.A. | Physical AppearancePowder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1157 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandMonoclate-P | CompanyN.A. | Physical AppearanceLyophilized powder for solution | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1158 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandReFacto | CompanyN.A. | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1159 | ThPPIDTh1022 | NameAntihemophilic Factor | Peptide SequenceATRRYYLGAVELSWDYMQSD Full view | Length255 | Functional ClassificationIa | DiseaseHematological,Metabolic | BrandXyntha | CompanyN.A. | Physical AppearanceSterile, nonpyrogenic, preservative-free, freeze-dried powder | Route of AdministartionIntravenous Injection | CategoryCoagulants and Thrombotic agents | TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2 |
ID1193 | ThPPIDTh1025 | NameIntravenous Immunoglobulin | Peptide SequenceIGG1:PSALTQPPSASGSLG Full view | Length250 | Functional ClassificationIa | DiseaseImmunological | BrandCivacir | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents | TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg |
ID1194 | ThPPIDTh1025 | NameIntravenous Immunoglobulin | Peptide SequenceIGG1:PSALTQPPSASGSLG Full view | Length250 | Functional ClassificationIa | DiseaseImmunological | BrandFlebogamma | CompanyInstituto Grifols SA | Physical AppearanceSterile, clear or slightly opalescent and colorless to pale yellow, liquid | Route of AdministartionIntravenous infusion | CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents | TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg |
ID1195 | ThPPIDTh1025 | NameIntravenous Immunoglobulin | Peptide SequenceIGG1:PSALTQPPSASGSLG Full view | Length250 | Functional ClassificationIa | DiseaseImmunological | BrandGamunex | CompanyTalecris Biotherapeutics | Physical AppearanceSterile solution | Route of AdministartionIntravenous infusion | CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents | TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg |
ID1201 | ThPPIDTh1026 | NameAnistreplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIc | DiseaseHematological,Metabolic | BrandEminase | CompanyWulfing Pharma GmbH | Physical AppearanceDry powder | Route of AdministartionIntravenous infusion | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1 |
ID1210 | ThPPIDTh1028 | NameTenecteplase | Peptide SequenceSYQVICRDEKTQMIYQQHQS Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandTNKase | CompanyGenentech Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous Injection | CategoryThrombolytic Agents, Fibrinolytic agents | TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1,Plasminogen activator inhibitor 2,Tetranectin,Keratin, type II cytoskeletal 8,Annexin A2,Calreticulin,Calnexin,Prolow-density lipoprotein |
ID1215 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandMenopur | CompanyN.A. | Physical AppearanceSterile, lyophilized powder which is reconstitution with sterile 0.9% Sodium Chloride Injection. | Route of AdministartionSubcutaneous Injection | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
ID1216 | ThPPIDTh1029 | NameMenotropins | Peptide SequenceAlpha-Chain(LH):APD< Full view | Length222 | Functional ClassificationIb | DiseaseHormonal disorders | BrandRepronex | CompanyN.A. | Physical AppearanceSterile, lyophilized form | Route of AdministartionSubcutaneous or Intramuscular Injection. | CategoryFertility Agents | TargetFollicle-stimulating hormone receptor,Lutropin-choriogonadotropic hormone receptor |
ID1234 | ThPPIDTh1032 | NameCoagulation factor VIIa | Peptide SequenceANAFLEELRPGSLERECKEE Full view | Length255 | Functional ClassificationIb | DiseaseHematological,Metabolic | BrandNovoSeven | CompanyNovo Nordisk | Physical AppearanceSterile, white lyophilized powder | Route of AdministartionInjection | CategoryThrombotic Agents, Coagulants | TargetCoagulation factor X,Serine protease hepsin,Tissue factor pathway inhibitor,Vitamin K-dependent gamma-carboxylase,Coagulation factor VII,Tissue factor |
ID1260 | ThPPIDTh1037 | NameBotulinum Toxin Type B | Peptide SequenceMPVTINNFNYNDPIDNNNII Full view | Length255 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandMyobloc | CompanySolstice Neurosciences | Physical AppearanceClear and colorless to light-yellow sterile injectable solution | Route of AdministartionInjection | CategoryAntidystonic Agents | TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2 |
ID1261 | ThPPIDTh1037 | NameBotulinum Toxin Type B | Peptide SequenceMPVTINNFNYNDPIDNNNII Full view | Length255 | Functional ClassificationIc | DiseaseNeurological Disorder | BrandNeurobloc | CompanySolstice Neurosciences | Physical AppearanceClear and colourless to light yellow solution | Route of AdministartionIntramuscular Injection | CategoryAntidystonic Agents | TargetVesicle-associated membrane protein 2,Vesicle-associated membrane protein 1,Synaptotagmin-2 |
ID1265 | ThPPIDTh1038 | NameOmalizumab | Peptide SequenceHeavy chain:EVQLVESG Full view | Length243 | Functional ClassificationIIa | DiseaseImmunological | BrandXolair | CompanyGenentech Inc | Physical AppearanceSterile, white, preservative free, lyophilized powde | Route of AdministartionSubcutaneous Injection | CategoryAnti-Allergic Agents, Anti-asthmatic, Immuno-suppressive agents | TargetHigh affinity immunoglobulin epsilon receptor subunit alpha and beta |
ID1269 | ThPPIDTh1039 | NameLutropin alfa | Peptide SequenceAlpha Chain: APDVQDC Full view | Length213 | Functional ClassificationIb | DiseaseHormonal | BrandLuveris | CompanySerono | Physical AppearanceWhite lyophilised pellet withg clear colourless solvent to make solution | Route of AdministartionSubcutaneous (SC) administration | CategoryFertility Agents | TargetLutropin-choriogonadotropic hormone receptor |
ID1288 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandCordase | CompanyN.A. | Physical AppearanceN.A. | Route of AdministartionN.A. | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1289 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandSantyl | CompanyAdvance Biofactures Corp | Physical AppearanceSterile enzymatic debriding ointment | Route of AdministartionExternal use only | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1290 | ThPPIDTh1042 | NameCollagenase | Peptide SequenceMKRKCLSKRLMLAITMATIF Full view | Length255 | Functional ClassificationIc | DiseaseHematological | BrandXiaflex | CompanyAuxilium | Physical AppearanceSterile lyophilized powder (white cake) | Route of AdministartionIntralesional Injection | CategoryN.A. | TargetCollagen alpha-1(I) chain,Collagen alpha-1(II) chain,Collagen alpha-1(III) chain,Collagen alpha-2(I) chain |
ID1305 | ThPPIDTh1043 | NameRasburicase | Peptide SequenceSAVKAARYGKDNVRVYKVHK Full view | Length255 | Functional ClassificationIc | DiseaseMetabolic/Genetic | BrandElitek | CompanySanofi-Synthelabo Inc | Physical AppearanceSterile, white to off-white, lyophilized powder | Route of AdministartionIntravenous administration | CategoryAntihyperuricemic Agents, Gout suppressants | TargetUric acid |
ID1306 | ThPPIDTh1043 | NameRasburicase | Peptide SequenceSAVKAARYGKDNVRVYKVHK Full view | Length255 | Functional ClassificationIc | DiseaseMetabolic/Genetic | BrandFasturtec | CompanyN.A. | Physical AppearancePowder and solvent that are made upto make solution. | Route of AdministartionIntravenous administartion | CategoryAntihyperuricemic Agents, Gout suppressants | TargetUric acid |
ID1316 | ThPPIDTh1044 | NameAdalimumab | Peptide SequenceLight-chain:DIQMTQS< Full view | Length230 | Functional ClassificationIc | DiseaseImmunological | BrandHumira | CompanyAbbott Laboratories | Physical AppearanceSterile, preservative-free solution | Route of AdministartionSubcutaneous administration | CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents | TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm |
ID1317 | ThPPIDTh1044 | NameAdalimumab | Peptide SequenceLight-chain:DIQMTQS< Full view | Length230 | Functional ClassificationIc | DiseaseOsteological | BrandHumira Pen | CompanyAbbott Laboratories | Physical AppearanceSterile, preservative-free solution | Route of AdministartionSubcutaneous injection | CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents | TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm |
ID1324 | ThPPIDTh1045 | NameImiglucerase | Peptide SequenceARPCIPKSFGYSSVVCVCNA Full view | Length255 | Functional ClassificationIa | DiseaseMetabolic | BrandCerezyme | CompanyGenzyme | Physical AppearanceSterile, non-pyrogenic, white to off-white lyophilized product | Route of AdministartionIntravenous infusion | CategoryEnzyme Replacement Agents | TargetGlucocerebroside |
ID1327 | ThPPIDTh1046 | NameAbciximab | Peptide SequenceH ReoPro-like antibo Full view | Length218 | Functional ClassificationIIa | DiseaseGenetic/Metabolic/Haemetological | BrandReoPro | CompanyEli Lilly and Company | Physical AppearanceClear, colorless, sterile, non-pyrogenic solution | Route of AdministartionIntravenous administartion | CategoryPlatelet Aggregation Inhibitors, Anticoagulants | TargetIntegrin beta-3,Integrin alpha-IIb,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immuno |
ID1331 | ThPPIDTh1047 | NameAlpha-1-proteinase inhibitor | Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view | Length255 | Functional ClassificationIIa | DiseaseMetabolic/Geneti/Respiratory | BrandAralast | CompanyBaxter | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous infusion | CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | TargetNeutrophil elastase |
ID1332 | ThPPIDTh1047 | NameAlpha-1-proteinase inhibitor | Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view | Length255 | Functional ClassificationIIa | DiseaseMetabolic/Geneti/Respiratory | BrandProlastin | CompanyTalecris Biotherapeutics C formerly Bayer | Physical AppearanceLyophilized powder | Route of AdministartionIntravenous infusion | CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | TargetNeutrophil elastase |
ID1337 | ThPPIDTh1048 | NamePegaspargase | Peptide SequenceMEFFKKTALAALVMGFSGAA Full view | Length255 | Functional ClassificationIc | DiseaseCancer | BrandOncaspar | CompanyEnzon Inc | Physical AppearanceSolution | Route of AdministartionIntravenous or Intramuscular administration | CategoryAntineoplastic Agents | TargetL-asparagine |
ID1358 | ThPPIDTh1050 | NamePegademase bovine | Peptide SequenceMAQTPAFNKPKVELHVHLDG Full view | Length255 | Functional ClassificationIa | DiseaseMetabolic | BrandAdagen | CompanyEnzon Inc. | Physical AppearanceIsotonic, pyrogen free, sterile solution, pH 7.2-7.4 | Route of AdministartionIntramusular Injection | CategoryEnzyme Replacement Agents | TargetAdenosine,Growth factor receptor-bound protein 2 |